NeuroTrauma Sciences LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2023-05-26
- Lead Sponsor
- NeuroTrauma Sciences, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT05547438
- Locations
- 🇺🇸
Parexel International EPCU Baltimore 7th floor, Baltimore, Maryland, United States
News
No news found